A new treatment for prostate cancer developed and trialled in London has been licensed for use.
Enzalutamide was developed by researchers at the Royal Marsden and University College London hospitals.
The one a day pill checks the spread of the cancer.
Reseachers say the most exciting aspect of this new drug is that is has very few side effects- unlike many cancer treatements.
More top news
Council workers uncovered the AK-74 concealed in the undergrowth.
The thief, who used a walking stick, was helped by a man who disabled the lock before pushing the woman away.
More than 40,000 new property millionaires have been created across Britain this year so far amid rising house prices.